<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">892</journal-id><journal-id journal-id-type="pmc-domain">vetres</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4176087</article-id><article-id pub-id-type="pmcid-ver">PMC4176087.1</article-id><article-id pub-id-type="pmcaid">4176087</article-id><article-id pub-id-type="pmcaiid">4176087</article-id><article-id pub-id-type="pmid">24176078</article-id><article-id pub-id-type="doi">10.1186/1297-9716-44-105</article-id><article-id pub-id-type="publisher-id">1297-9716-44-105</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Deletion of the GI-2 integrase and the <italic toggle="yes">wbkA</italic> flanking transposase improves the stability of <italic toggle="yes">Brucella melitensis</italic> Rev 1 vaccine</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name name-style="western"><surname>Mancilla</surname><given-names initials="M">Marcos</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>mancilla.marcos@gmail.com</email></contrib><contrib contrib-type="author" id="A2"><name name-style="western"><surname>Grill&#243;</surname><given-names initials="MJ">Mar&#237;a-Jes&#250;s</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mariajesus.grillo@unavarra.es</email></contrib><contrib contrib-type="author" id="A3"><name name-style="western"><surname>de Miguel</surname><given-names initials="MJ">Mar&#237;a-Jes&#250;s</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>mjmiguel@aragon.es</email></contrib><contrib contrib-type="author" id="A4"><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names initials="I">Ignacio</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ilgoni@unav.es</email></contrib><contrib contrib-type="author" id="A5"><name name-style="western"><surname>San-Rom&#225;n</surname><given-names initials="B">Beatriz</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>beatriz.sanroman@unavarra.es</email></contrib><contrib contrib-type="author" id="A6"><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names initials="A">Ana</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>ana.zabalzab@unavarra.es</email></contrib><contrib contrib-type="author" corresp="yes" id="A7"><name name-style="western"><surname>Moriy&#243;n</surname><given-names initials="I">Ignacio</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>imoriyon@unav.es</email></contrib></contrib-group><aff id="I1"><label>1</label>Departamento de Microbiolog&#237;a y Parasitolog&#237;a e Instituto de Salud Tropical, Universidad de Navarra, C/ Irunlarrea, 1, 31008 Pamplona, Spain</aff><aff id="I2"><label>2</label>Instituto de Bioqu&#237;mica y Microbiolog&#237;a, Universidad Austral de Chile, Campus Isla Teja, casilla 567, Valdivia, Chile</aff><aff id="I3"><label>3</label>Grupo de Sanidad Animal, Instituto de Agrobiotecnolog&#237;a (CSIC-Universidad P&#250;blica de Navarra-Gobierno de Navarra), Campus de Arrosad&#237;a, 31006 Pamplona, Spain</aff><aff id="I4"><label>4</label>Unidad de Sanidad Animal, Centro de Investigaci&#243;n y Tecnolog&#237;a Agroalimentaria de Arag&#243;n (CITA), Gobierno de Arag&#243;n. Av. Monta&#241;ana, 930, 50059 Zaragoza, Spain</aff><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>31</day><month>10</month><year>2013</year></pub-date><volume>44</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">218953</issue-id><fpage>105</fpage><lpage>105</lpage><history><date date-type="received"><day>17</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>21</day><month>10</month><year>2013</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2013</year></date></event><event event-type="pmc-live"><date><day>27</day><month>09</month><year>2014</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-22 19:25:33.757"><day>22</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2013 Mancilla et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Mancilla et al.; licensee BioMed Central Ltd.</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1297-9716-44-105.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.veterinaryresearch.org/content/44/1/105"/><abstract><p><italic toggle="yes">Brucella melitensis</italic> Rev 1 is the best vaccine available for the prophylaxis of small ruminant brucellosis and, indirectly, for reducing human brucellosis. However, Rev 1 shows anomalously high rates of spontaneous dissociation from smooth (S) to rough (R) bacteria, the latter being inefficacious as vaccines. This S-R instability results from the loss of the O-polysaccharide. To overcome this problem, we investigated whether some recently described mechanisms promoting mutations in O-polysaccharide genes were involved in Rev 1&#160;S-R dissociation. We found that a proportion of Rev 1 R mutants result from genome rearrangements affecting the <italic toggle="yes">wbo</italic> O-polysaccharide loci of genomic island GI-2 and the <italic toggle="yes">wbkA</italic> O-polysaccharide glycosyltransferase gene of the <italic toggle="yes">wbk</italic> region. Accordingly, we mutated the GI-2 <italic toggle="yes">int</italic> gene and the <italic toggle="yes">wbk</italic> IS transposase involved in those arrangements, and found that these Rev 1 mutants maintained the S phenotype and showed lower dissociation levels. Combining these two mutations resulted in a strain (Rev 2) displaying a 95% decrease in dissociation with respect to parental Rev 1 under conditions promoting dissociation. Rev 2 did not differ from Rev 1 in the characteristics used in Rev 1 typing (growth rate, colonial size, reactivity with O-polysaccharide antibodies, phage, dye and antibiotic susceptibility). Moreover, Rev 2 and Rev 1 showed similar attenuation and afforded similar protection in the mouse model of brucellosis vaccines. We conclude that mutations targeting genes and DNA sequences involved in spontaneous O-polysaccharide loss enhance the stability of a critical vaccine phenotype and complement the empirical stabilization precautions taken during S <italic toggle="yes">Brucella</italic> vaccine production.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The members of the genus <italic toggle="yes">Brucella</italic> are gram-negative bacteria that cause brucellosis, an infection affecting domestic and wild animals as well as human beings. The genus includes several species among which <italic toggle="yes">B. melitensis</italic>, <italic toggle="yes">B. abortus</italic> and <italic toggle="yes">B. suis</italic> are the main cause of brucellosis in domestic livestock. <italic toggle="yes">B. melitensis</italic> preferentially infects sheep and goats and represents the most common cause of human brucellosis, a severe and debilitating disease endemic in large areas of Africa, the Middle East, Asia and Latin America [<xref ref-type="bibr" rid="B1">1</xref>]. This distribution reflects the problems associated with the control and eradication of a zoonotic disease in areas where extensive breeding and infrastructure weaknesses are combined. Accordingly, the World Health Organization has classified brucellosis as one of the top neglected zoonosis, a group of diseases that hamper development and contribute to the perpetuation of poverty [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>The most effective measure to control brucellosis is the vaccination of the host ruminants [<xref ref-type="bibr" rid="B3">3</xref>]. Several vaccines have been developed for this purpose but the smooth (S) attenuated <italic toggle="yes">B. abortus</italic> S19 and <italic toggle="yes">B. melitensis</italic> Rev 1 strains are superior in controlled experiments [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>] and the only ones that have proved their usefulness in successful eradication programs. Human-to-human contagion is only anecdotal, and there is abundant evidence showing that the correct use of vaccine Rev 1 results in a parallel decrease of human brucellosis, as illustrated by the experience in Greece [<xref ref-type="bibr" rid="B7">7</xref>]. Indeed, the use of a vaccine of good quality is essential and, in this regard, Rev 1 is not lacking problems. It is well know that, as compared to virulent <italic toggle="yes">B. melitensis</italic>, Rev 1 has a marked tendency to undergo the smooth-rough (S-R) dissociation that results in a dominancy of non-immunogenic R mutants that make the vaccine ineffective [<xref ref-type="bibr" rid="B8">8</xref>]. Indeed, procedures that minimize the S-R dissociation and controls to exclude batches containing R bacteria are critical in Rev 1 production [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>In the brucellae, the S-R dissociation is caused by the spontaneous mutations leading to the loss of the O-polysaccharide (O-PS) of the outer membrane lipopolysaccharide (LPS). The LPS O-PS genes are concentrated in two genetic regions: <italic toggle="yes">wbk</italic> (which includes genes of glycosiltransferases, enzymes for the synthesis of precursors and bactoprenol priming, and several insertion sequences [IS]) and <italic toggle="yes">wbo</italic> (carrying the <italic toggle="yes">wboA</italic> and <italic toggle="yes">wboB</italic> glycosyltransferase genes), the latter being part of genomic island 2 (GI-2) [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. Other genes coding for glycosyltransferases and synthesis of precursors are scattered in the genome [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Although the causes of the S-R dissociation have not been completely elucidated, there have been recent advances in our understanding of the main genetic mechanisms involved. In wild-type <italic toggle="yes">B. abortus</italic>, the spontaneous excision of 15.1&#160;kb GI-2 island (which removes the <italic toggle="yes">wboA</italic> and <italic toggle="yes">wboB</italic> loci) by recombination promoted by the GI-2-encoded integrase (<italic toggle="yes">int</italic>) is one of the main sources of S-R dissociation, and identical dissociation mechanisms have been proposed for <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. suis</italic> (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>A) [<xref ref-type="bibr" rid="B10">10</xref>]. A similar spontaneous recombination and excision affects <italic toggle="yes">wbkA</italic> (a <italic toggle="yes">wbk</italic> glycosyltransferase gene), in this case mediated by RecA, which recognizes the flanking <italic toggle="yes">wbkA</italic> transposases as substrates for homologous recombination [<xref ref-type="bibr" rid="B14">14</xref>] (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>B). In both cases, the resulting R mutants carry a chromosomal scar that results from the release of a circular intermediate (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>A and <xref ref-type="fig" rid="F1">1</xref>B) that is lost in subsequent rounds of replication. In addition, a proportion of R mutants result from random mutations affecting the <italic toggle="yes">manB</italic><sub>core</sub> gene and possibly other LPS genes related to the synthesis of O-PS and core oligosaccharide precursors and their assembly [<xref ref-type="bibr" rid="B15">15</xref>]. The R phenotype of the <italic toggle="yes">B. abortus</italic> RB51 vaccine is also known to relate in part to the disruption of gene <italic toggle="yes">wboA</italic> of GI-2 by IS711 (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>D), which indicates the mobility of IS<italic toggle="yes">711</italic> as a source of R mutations [<xref ref-type="bibr" rid="B16">16</xref>]. Examination of the LPS genes of <italic toggle="yes">B. canis</italic> and <italic toggle="yes">B. ovis</italic>, two naturally R species, confirms some of the above mechanisms and reveals additional possibilities for the generation of defective LPS. <italic toggle="yes">B. canis</italic> carries a deletion encompassing genes <italic toggle="yes">wbkD</italic> and <italic toggle="yes">wbkF</italic> (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>C) probably generated by a slipped mispairing mechanism [<xref ref-type="bibr" rid="B17">17</xref>]. <italic toggle="yes">B. ovis</italic> lacks GI-2 (and bears the corresponding genomic scar) and carries mutations affecting <italic toggle="yes">manB</italic><sub>core</sub>, <italic toggle="yes">wbkF</italic> and other <italic toggle="yes">wbk</italic> genes (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>E) [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>].</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Genetic organization of regions encoding LPS genes that are susceptible to mutation with a subsequent generation of R mutants. (A)</bold> GI-2 region of <italic toggle="yes">B. melitensis</italic> and the scar and circular intermediate (<italic toggle="yes">wbo</italic> genes are omitted in the circular intermediate) resulting from the <italic toggle="yes">int</italic>- promoted excision; <bold>(B)</bold><italic toggle="yes">wbkA</italic> region and the corresponding scar and circular intermediate resulting from homologous recombination between IS<italic toggle="yes">Bm1</italic> transposases; <bold>(C)</bold> the <italic toggle="yes">wbk</italic>FD region of <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. canis</italic> (wbkD is annotated as capD in B. canis); <bold>(D)</bold><italic toggle="yes">wbo</italic> locus in <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. abortus</italic> RB51 and <bold>(E)</bold><italic toggle="yes">manBA</italic><sub>core</sub> locus in <italic toggle="yes">B. melitensis</italic> chromosome II with its corresponding mutants showing the deletion and point mutations in <italic toggle="yes">manB</italic><sub>core</sub> gene (asterisks). The position of the primers used in the PCR analyses is indicated as P-number of the primer. The ORF annotations are based on the <italic toggle="yes">B. melitensis</italic> 16&#160;M genome [GenBank: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AE008917">AE008917</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AE008918">AE008918</ext-link>] and <italic toggle="yes">B. canis</italic> chromosome I [GenBank: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="CP000872">CP000872</ext-link>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1297-9716-44-105-1.jpg"/></fig><p>Since GI-2 and region <italic toggle="yes">wbk</italic> are conserved in S brucellae, we hypothesized that GI-2 and <italic toggle="yes">wbkA</italic> excisions could be involved in the S-R dissociation of vaccine Rev 1, and that the stability of this vaccine could be improved. Here we show that these two mechanisms account for the majority of the mutations involved in the S-R dissociation of this vaccine. We also show that mutation of the <italic toggle="yes">int</italic> gene in GI-2 and the IS-sequences flanking <italic toggle="yes">wbkA</italic> in Rev 1 stabilizes the S phenotype without altering the biologically relevant characteristics of the vaccine<italic toggle="yes">.</italic> Accordingly, we propose the corresponding double GI-2 <italic toggle="yes">int</italic> and <italic toggle="yes">wbkA</italic> IS mutant of Rev 1 as an improved, more stable vaccine against <italic toggle="yes">B. melitensis</italic> infection in small ruminants.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Bacterial strains and culture conditions</title><p>The <italic toggle="yes">Brucella</italic> strains used are listed in Table&#160;<xref ref-type="table" rid="T1">1</xref>, and the <italic toggle="yes">E. coli</italic> strains and plasmids are in Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>. For S-R dissociation experiments, three lots of commercial Rev 1 vaccine showing 0%, 5% and 100% of dissociation (determined by the crystal violet exclusion method, following the standard protocol for vaccine quality control [<xref ref-type="bibr" rid="B8">8</xref>]) were selected from a collection kept in the Centro de Investigaci&#243;n y Tecnolog&#237;a Agroalimentaria of Arag&#243;n (CITA), Zaragoza, Spain. Bacteria were grown either on trypticase soy agar (TSA; Becton Dickinson, Madrid, Spain), Blood Agar Base number 2 (BAB; Oxoid, Hampshire, UK) plates (37&#160;&#176;C, 1&#8211;5&#160;days) or in trypticase soy broth (TSB; Becton Dickinson, Madrid, Spain). For cloning, <italic toggle="yes">E. coli</italic> was grown in Luria-Bertani broth (LB; Becton Dickinson, Madrid, Spain) supplemented with kanamycin (Km; 50&#160;&#956;g/mL) or chloramphenicol (Ch; 20&#160;&#956;g/mL). Subcultures in BAB supplemented with nalidixic acid (Nx; 25 &#956;g/mL) were used for obtaining the <italic toggle="yes">B. melitensis</italic> H38-Nx<sup>R</sup> spontaneous variant used as challenge strain in vaccine experiments in mice.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p><bold>
<italic toggle="yes">Brucella </italic>
</bold><bold>strains used.</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="top"><tr><th align="left" colspan="1" rowspan="1"><bold>Strain</bold></th><th align="left" colspan="1" rowspan="1"><bold>Characteristics</bold></th><th align="left" colspan="1" rowspan="1"><bold>Source/ reference</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">B. melitensis</italic> H38<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">B. melitensis</italic> smooth virulent strain; S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">CITA collection<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">H38-Nx<sup>R</sup><hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">B. melitensis</italic> H38 spontaneous mutant resistant to nalidixic acid; challenge studies in mice; S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1"><italic toggle="yes">B. melitensis</italic> smooth attenuated reference vaccine strain; S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">CITA collection<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;<italic toggle="yes">wbkA</italic><hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1 spontaneous deletion mutant in <italic toggle="yes">wbkA</italic> (ORF BMEI1398 and BME1412); R-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;GI-2<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1 spontaneous deletion mutant in GI-2; R-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;IS<italic toggle="yes">Bm1</italic><hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1 in-frame deletion mutant in IS<italic toggle="yes">Bm-1</italic> transposase gene (ORF BMEI1398 and BME1400); S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;<italic toggle="yes">int</italic><hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1 in-frame deletion mutant in GI-2 phage-integrase gene (nucleotides <italic toggle="yes">int</italic><sub>&#916;53&#8211;286</sub>); S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 2(&#916;IS<italic toggle="yes">Bm1</italic>&#916;<italic toggle="yes">int</italic>)<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1 double in-frame deletion mutant in IS<italic toggle="yes">Bm-1</italic> transposase and GI-2 phage-integrase; S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;<italic toggle="yes">wbkA</italic>/c<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;<italic toggle="yes">wbkA</italic> rough spontaneous mutant complemented with plasmid pMM14; S-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;GI-2/<italic toggle="yes">wboAB</italic><hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">Rev 1&#916;GI-2 rough spontaneous mutant containing the plasmid pMM76; R-LPS<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This work<hr/></td></tr><tr><td align="left" colspan="1" rowspan="1">Rev 1&#916;GI-2/c</td><td align="left" colspan="1" rowspan="1">Rev 1&#916;GI-2 rough spontaneous mutant complemented with plasmid pBGI-997-99c; S-LPS</td><td align="left" colspan="1" rowspan="1">This work</td></tr></tbody></table><table-wrap-foot><p>S-LPS: smooth lipopolysaccharide; CITA: Centro de Investigaci&#243;n y Tecnolog&#237;a Agroalimentaria of Arag&#243;n (Zaragoza, Spain); R-LPS: rough lipopolysaccharide; GI-2: Genomic Island 2.</p></table-wrap-foot></table-wrap></sec><sec><title>Sequence analyses</title><p>Confirmation of constructed mutant genotypes and analysis of <italic toggle="yes">manB</italic><sub>core</sub> locus in spontaneous R mutants was carried out on PCR fragments by DNA sequencing, using the dideoxy method at the Sequencing Unit of Centro de Investigaci&#243;n M&#233;dica Aplicada (CIMA, Universidad de Navarra, Spain). In silico mutants were designed using the complete sequence of chromosome I of <italic toggle="yes">B. melitensis</italic> 16&#160;M as template [GenBank: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AE008917">AE008917</ext-link>] [<xref ref-type="bibr" rid="B18">18</xref>]. Similarity searches were performed by BLAST [<xref ref-type="bibr" rid="B19">19</xref>] and sequence alignments by Clustal Omega [<xref ref-type="bibr" rid="B20">20</xref>]. In silico restriction analyses of <italic toggle="yes">wbo</italic> and <italic toggle="yes">wbk</italic> regions were performed with Vector NTI software (Invitrogen, USA).</p></sec><sec><title>PCR assays</title><p>The primers designed to identify mutations known to affect the O-PS generating R phenotypes are indicated in Figure&#160;<xref ref-type="fig" rid="F1">1</xref> and listed in Table&#160;<xref ref-type="table" rid="T2">2</xref>. In addition, primers BMEI0993F and BMEI1013R (GI-2 deletion) or BMEI1398F and BMEI1413R (<italic toggle="yes">wbkA</italic> deletion) were used for detecting chromosomal scars, and primers BMEI0994R and BMEI1012bF (GI-2 region) or BMEI1400R and BMEI1409F (<italic toggle="yes">wbkA</italic> gene) were used for detecting the circular intermediates. Primers were generated with Primer3 software [<xref ref-type="bibr" rid="B21">21</xref>]. Genomic DNA (gDNA) was obtained by using standard protocols [<xref ref-type="bibr" rid="B22">22</xref>] or boiling (95 &#176;C, 10&#160;min) either directly from bacterial colonies grown in TSA plates or from Rev 1 commercial vaccine vials rehydrated in saline. PCR assays were performed in a final volume of 25&#160;&#956;L containing 0.2&#160;&#956;g of gDNA, 12.5 pmol of the correspondent primer, 0.2&#160;mM of dNTPs, 2&#160;mM of MgCl<sub>2</sub> and 1U of Immolase DNA polymerase (Bioline, London, UK). The mixture was pre-incubated at 95&#160;&#176;C for 5&#160;min, followed by 30&#160;cycles (95&#160;&#176;C for 20&#160;s; 60&#160;&#176;C for 30&#160;s; and 72&#160;&#176;C for 1&#160;min) with a final extension at 72&#160;&#176;C for 5&#160;min. All PCR rounds were carried out in a Mastercycler gradient PCR machine (Eppendorf, Hamburg, Germany). Amplicons and restriction fragments were resolved by electrophoresis in 1.0-2.0% TBE (45&#160;mM Tris-borate, 1&#160;mM EDTA pH 8.0) agarose gels. All PCR experiments included DNA from S Rev 1 as a control.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>List of oligonucleotides used.</p></caption><table frame="hsides" rules="groups" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="top"><tr><th align="left" colspan="1" rowspan="1"><bold>Name</bold></th><th align="left" colspan="1" rowspan="1"><bold>Sequence (5&#8242;&#8594; 3&#8242;)</bold></th><th align="left" colspan="1" rowspan="1"><bold>Name in Figure</bold><xref ref-type="fig" rid="F1">1</xref></th><th align="left" colspan="1" rowspan="1"><bold>Reference</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom" colspan="1" rowspan="1">711u<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">cacaagactgcgttgccgacaga<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">711d<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">catatgatgggaccaaacacctaggg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0999F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">cacgatcaaaacgatgccct<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0999R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ccaaaatgtcctgagcttgg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1404F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">aagggctggaacctaggaga<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1404R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">aatgacttccgctgccatag<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0993F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">caacatcgcaaagcctgaaa<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P1<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1013R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">cgcaatccagccaatacctg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P2<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0994R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">atcgtcggcattgtctctct<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P3<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1012bF<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">attatccggcggtatgtgag<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P4<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B10">10</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1398F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">gatcttggtatcggcctgtc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P5<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1413R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">tgcgactttcttcacgattg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P6<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1400R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">cgctttaatatctcgcgttcc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P7<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1409F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ggtcccatcggcatatctt<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P8<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1426F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ctggagtgtgccgaaagtg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P9<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1427R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">gctgatctcttccgacaagg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P10<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0998F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ttaagcgctgatgccatttccttcac<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P11<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI0998R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">gccaaccaacccaaatgctcacaa<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P12<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEII0898F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">tcggcacagcaagctataaa<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P13<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEII0912R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ggtgtggatattgcgctttc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P14<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEII0899F<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ccgcctatgcctatacgatg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P15<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEII0899R<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">gcctcatcatccttgtcgat<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">P16<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1401_F1<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ttctcgagagcctgaagagc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1401_R2<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">gccttcgtcgagaaaatgag<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1397_F3<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ctcattttctcgacgaaggccgtttgcatcaatcagttcg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1397_R4<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">ctcggctggcagtatctttc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1012_F1<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">caaagagctaagggcattcg<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1012_R2<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">cgcgaaactttgaagcatct<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" valign="bottom" colspan="1" rowspan="1">BMEI1012_F3<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">agatgcttcaaagtttcgcgtctatatcgccggtctgtcc<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">&#160;<hr/></td><td align="left" valign="bottom" colspan="1" rowspan="1">This study<hr/></td></tr><tr><td align="left" colspan="1" rowspan="1">BMEI1012_R4</td><td align="left" colspan="1" rowspan="1">tttcagtgctttatgacgaaaat</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">This study</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">F</italic>, forward; <italic toggle="yes">R</italic>, reverse.</p></table-wrap-foot></table-wrap></sec><sec><title>Southern blot</title><p>The distribution of IS<italic toggle="yes">711</italic> sequences was assessed by Southern blot using 1&#8211;2&#160;&#956;g of <italic toggle="yes">Ava</italic>I-<italic toggle="yes">Cla</italic>I double digested gDNA from <italic toggle="yes">B. melitensis</italic> Rev 1 related-strains as previously described [<xref ref-type="bibr" rid="B23">23</xref>]. Restriction fragments were resolved in 1% agarose-TBE at 25&#160;mA for 10&#160;h and probed with ECL direct-labeled system (GE Healthcare, Waukesha, WI, USA). IS<italic toggle="yes">711</italic> fragment was generated by PCR with primers 711u and 711d as well as the corresponding GI-2 (~1.4&#160;kb, BMEI0999 primers) and <italic toggle="yes">wbkA</italic> (332&#160;bp, BMEI1404 primers) specific DNA probes (Table&#160;<xref ref-type="table" rid="T2">2</xref>). Chemiluminiscent detection of the hybridized product was performed using a commercial kit (GE Healthcare, Madrid, Spain) and enhanced ECL Films for developing by conventional photographic methods. Blots were stripped with 1% SDS at 80&#160;&#176;C for 30&#160;min and EDTA 20&#160;mM at room temperature for 15&#160;min, and then analyzed for the presence of GI-2 and <italic toggle="yes">wbkA</italic> with specific DNA probes.</p></sec><sec><title>Mutagenesis</title><p>The Rev 1 strain used in these experiments was a vaccine seed lot of proved efficacy. It was generously provided by Dr J.M. Blasco (CITA of Arag&#243;n, Spain). For mutagenesis, a parental Rev 1 clone was selected directly from colonies grown on agar according to morphology, size and agglutination criteria previously described [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. A first Rev 1 (&#916;IS<italic toggle="yes">Bm1</italic> strain) mutant carrying a deletion of 872&#160;bp spanning ORFs BMEI1398-1400 (IS<italic toggle="yes">Bm1</italic> complete transposase) was constructed by allelic exchange [<xref ref-type="bibr" rid="B26">26</xref>]. Briefly, PCR fragments produced with primers pairs BMEI1401_F1, R2 and BMEI1397_F3, R4 (Table&#160;<xref ref-type="table" rid="T2">2</xref>) were ligated by PCR overlap, and the resulting fragment was cloned into pCR2.1 TOPO (Invitrogen, USA) to produce plasmid pMM20. The <italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Not</italic>I fragment of pMM20 was subcloned into plasmid pJQK [<xref ref-type="bibr" rid="B27">27</xref>] to generate the pMM22 suicide vector, which was transferred to Rev 1 by conjugation using <italic toggle="yes">E. coli</italic> S17-1&#955;<italic toggle="yes">pir</italic>[<xref ref-type="bibr" rid="B28">28</xref>]. Double crossover transconjugants were selected on polymyxin 1.5&#160;&#956;g/mL and sucrose 5% plates, and the mutants were identified by PCR. The same strategy was used to construct a Rev 1&#916;<italic toggle="yes">int</italic> (BMEI1012) non-polar mutant. Two fragments generated with primer pairs BMEI1012_F1, R2 and BMEI1012_F3, R4 (Table&#160;<xref ref-type="table" rid="T2">2</xref>) were ligated by PCR. The resulting fragment containing a copy of <italic toggle="yes">int</italic> lacking the nucleotides encoding amino acids 53&#8211;286 was cloned into pCR2.1 TOPO to produce the plasmid pMM55. Then, the <italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Xba</italic>I fragment of pMM55 was subcloned into the plasmid pJQK to generate the pMM56 suicide vector, which in turn was transferred to Rev 1 by conjugation, and the mutants were identified by PCR. Mutant Rev 1 &#916;IS<italic toggle="yes">Bm1</italic> was used to construct the double mutant &#916;IS<italic toggle="yes">Bm1</italic>&#916;<italic toggle="yes">int</italic> (hereafter Rev 2) using the mutator plasmid pMM56. Maintenance of the reading frame was verified by sequencing of suicide vectors and of PCR amplified fragments of the final constructs [<xref ref-type="bibr" rid="B26">26</xref>].</p></sec><sec><title>Complementation</title><p>To confirm the origin of the mutation, spontaneous Rev 1 R strains lacking <italic toggle="yes">wbkA</italic> were complemented with plasmid pMM14, which carries a copy of <italic toggle="yes">wbkA</italic>[<xref ref-type="bibr" rid="B14">14</xref>]. In the case of spontaneous &#916;GI-2 Rev1 R mutants, plasmids pMM76 (carrying <italic toggle="yes">wboA</italic>-<italic toggle="yes">wboB</italic>) or pBGI-997-99c (carrying <italic toggle="yes">wboA</italic>-<italic toggle="yes">wboB</italic> plus ORF BMEI0999) were used [<xref ref-type="bibr" rid="B29">29</xref>].</p></sec><sec><title>S-R dissociation assessment</title><p>A loop of bacteria previously grown on TSA plates for 72&#8211;96&#160;h at 37&#160;&#176;C was transferred to a flask containing 10&#160;mL of TSB, and the flask was incubated until bacteria reached the stationary phase (37&#160;&#176;C, 72&#8211;96&#160;h). An aliquot of this culture was adjusted to 0.109 of optical density at 750&#160;nm (equivalent to 10<sup>8</sup>&#160;CFU/mL) using sterile TSB and then diluted 1:100 in the same broth. After incubation for 3&#8211;4&#160;days at 37&#160;&#176;C, serial ten-fold dilutions were plated on TSA, plates were incubated (37&#160;&#176;C, 5&#160;days), and S-R dissociation was assessed by the crystal violet exclusion method and the R phenotypes confirmed by agglutination with 0.1% acriflavine [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Dissociation rate was calculated as the ratio between the number of R colonies and the total colony counts. In addition, commercial Rev 1 vaccine lots were analyzed for dissociation by PCR amplification (see above) of &#8710;GI-2 and &#8710;<italic toggle="yes">wbkA</italic> chromosomal scars using DNA obtained directly from vaccine batches reconstituted as recommended by the manufacturers.</p></sec><sec><title>Bacteriological characterization</title><p><italic toggle="yes">Brucella</italic> spp. and Rev 1-specific phenotypic characteristics were confirmed or assessed by established procedures [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. In addition, growth curves were obtained in a BioScreen C [<xref ref-type="bibr" rid="B30">30</xref>] apparatus. For this, the parental Rev 1, the Rev 2 double mutant &#916;IS<italic toggle="yes">Bm1</italic>&#916;<italic toggle="yes">int</italic> and the virulent <italic toggle="yes">B. melitensis</italic> H38 (as a control) were inoculated (5 &#215; 10<sup>6</sup>&#160;CFU/well) by triplicate in Bioscreen multi-well plates containing 250 &#956;L/well of TSB, and the optical density was read at 600&#160;nm wavelength (O.D.<sub>600</sub>) at 10&#160;min intervals, until to reach the stationary phase.</p></sec><sec><title>LPS characterization</title><p>The S or R nature of LPS of the mutant and complemented strains was analyzed by Western blot of SDS-proteinase K extracts using the serum of a rabbit immunized with <italic toggle="yes">B. melitensis</italic> 16&#160;M [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. Purified S and R-LPS obtained as described previously [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B31">31</xref>] were used as controls.</p></sec><sec><title>Experiments in mice</title><p>The biological properties of Rev 1&#916;IS<italic toggle="yes">Bm1</italic>&#916;<italic toggle="yes">int</italic> mutant (Rev 2) determined in comparison with the reference Rev 1 vaccine were virulence and protective efficacy in the mouse model. Female BALB/c mice 7&#8211;8&#160;weeks old were purchased from Charles River International (France) and accommodated in the animal facilities of CITA (registration code ES/50-2970-12005) or Universidad P&#250;blica de Navarra (UPNA; registration code ES/31-2016-000002 CR-SU-US) for 1&#8211;2&#160;weeks before starting and during the assays, with water and food <italic toggle="yes">ad libitum</italic>. Animal handling was performed in compliance with current European and national (RD 53/2013) regulations, following the FELASA and ARRIVE guidelines, and with the approval of the CITA or UPNA Animal Experimentation Committees and local Government authorization (approval reference number R130/2012). Mice inoculations were carried out with 0.1&#160;mL of bacterial suspension previously adjusted to an optical density at 600&#160;nm of 0.170 (approximately 1 &#215; 10<sup>9</sup>&#160;CFU/mL) and then diluted to the appropriate dose (see below) in sterile phosphate buffered saline [<xref ref-type="bibr" rid="B32">32</xref>]. For virulence, groups of 30 mice each were inoculated intraperitoneally with 1 &#215; 10<sup>5</sup>&#160;CFU/mouse of Rev 2 or Rev 1 attenuated strains. As a control, an additional group of 30 mice were inoculated similarly with the virulent <italic toggle="yes">B. melitensis</italic> H38 reference strain. Spleen weights and viable counts (<italic toggle="yes">n</italic> = 5) were determined at 1, 3, 6, 9, 12 and 15&#160;weeks post-inoculation as described previously [<xref ref-type="bibr" rid="B32">32</xref>]. The identity of the spleen isolates was confirmed by PCR, and the constancy of the typical Rev 1 phenotypic features confirmed throughout the experiments. Spleen weights were expressed as the mean and SD (<italic toggle="yes">n</italic> = 5) of grams/spleen and the level of spleen infections as mean &#177; SD (<italic toggle="yes">n</italic> = 5) of individual log<sub>10</sub> CFU/spleen at the indicated times.</p><p>Efficacy studies were carried out in groups of 5 BALB/c mice each vaccinated subcutaneously with 1 &#215; 10<sup>5</sup>&#160;CFU/mouse of Rev 2 or Rev 1 (parental control), or with 0.1&#160;mL of phosphate buffered saline (pH 6.85) as the placebo vaccinated control. Four weeks after vaccination, all mice were challenged intraperitoneally with 1 &#215; 10<sup>4</sup>&#160;CFU/mouse of <italic toggle="yes">B. melitensis</italic> H38-Nx<sup>R</sup>, and the number of challenge bacteria in spleens was determined 2&#160;weeks afterwards [<xref ref-type="bibr" rid="B32">32</xref>]. Differentiation between challenge and residual vaccine bacteria was performed by double plating on BAB and BAB supplemented with Nx 25 &#956;g/mL. The results were expressed as the mean and SD (<italic toggle="yes">n</italic> = 5) of the log<sub>10</sub> of <italic toggle="yes">B. melitensis</italic> H38-Nx<sup>R</sup>/spleen. In a previous work, the virulence in mice of the <italic toggle="yes">B. melitensis</italic> H38-Nx<sup>R</sup> challenge strain used in this work was found to be indistinguishable from that of the reference H38 and 16&#160;M strains [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>In both virulence and protection experiments, statistical comparisons of means were performed by a one-way ANOVA followed by the Fisher&#8217;s Protected Least Significant Differences tests [<xref ref-type="bibr" rid="B32">32</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Deletions involving GI-2 and <italic toggle="yes">wbkA</italic> are the major causes of S-R dissociation of <italic toggle="yes">B. melitensis</italic> Rev 1</title><p>As a first approach to determine the dissociation mechanisms operating in Rev 1, we searched for &#8710;GI-2 and &#8710;<italic toggle="yes">wbkA</italic> chromosomal scars, for deletions in <italic toggle="yes">wbkF</italic> and <italic toggle="yes">wbkD</italic>, insertion of IS elements on <italic toggle="yes">wboA</italic> and <italic toggle="yes">manB</italic><sub>core</sub> mutations (Figure&#160;<xref ref-type="fig" rid="F1">1</xref>) in Rev 1 spontaneous R mutants. To this end, we studied a collection of 32 R Rev 1 isolates (previously obtained by repeated plating on TSA and crystal violet and acriflavine agglutination screening) and characterized them by PCR using the primers described in Table&#160;<xref ref-type="table" rid="T1">1</xref>. We found 8 &#916;GI-2 and 3 &#916;<italic toggle="yes">wbkA</italic> mutants, but we did not detect redundancy or other mutations known to generate R phenotypes in <italic toggle="yes">Brucella</italic>, including point mutations in <italic toggle="yes">manB</italic><sub>core</sub> in the remaining 21 mutants.</p><p>To confirm that the above observations corresponded in fact to the expected GI-2 or <italic toggle="yes">wbkA</italic> deletions and O-PS defects, we first characterized Rev 1 R mutants by IS<italic toggle="yes">711</italic>-fingerprinting using DNA probes specific for the <italic toggle="yes">wbkA</italic> and GI-2 loci. We found that, as predicted, &#916;GI-2 and &#916;<italic toggle="yes">wbkA</italic> Rev 1 mutants lacked the IS<italic toggle="yes">711</italic> bands of 4.2 and 3.8&#160;kb, respectively (Figure&#160;<xref ref-type="fig" rid="F2">2</xref>A). Second, we examined the LPS phenotype by Western blot. Figure&#160;<xref ref-type="fig" rid="F2">2</xref>B shows that the LPS of the Rev 1 mutants lacked the O-PS. Third, we performed complementation experiments in eleven R mutants using plasmids encoding the <italic toggle="yes">wbkA</italic> (pMM14) or the tandem <italic toggle="yes">wboA</italic>-<italic toggle="yes">wboB</italic> of GI-2 (pMM76). We found that the 3 spontaneous Rev 1 &#916;<italic toggle="yes">wbkA</italic> R isolates were complemented with plasmid pMM14 (a representative result can be seen in Figure&#160;<xref ref-type="fig" rid="F2">2</xref>B, lane &#916;<italic toggle="yes">wbkA</italic>/c). However, we repeatedly failed to complement the Rev 1 &#916;GI-2 R isolates with plasmid pMM76 (not shown). Rajashekara et al. [<xref ref-type="bibr" rid="B29">29</xref>] demonstrated that artificially constructed <italic toggle="yes">B. melitensis</italic> &#916;GI-2 R mutants could be reverted to S phenotype with a plasmid (pBGI-997-99c) bearing <italic toggle="yes">wboA</italic> and <italic toggle="yes">wboB</italic> plus ORF BMEI0999. Using this approach, we could revert 8 spontaneous Rev 1 &#916;GI-2 R isolates (a representative result can be seen in Figure&#160;<xref ref-type="fig" rid="F2">2</xref>B, lane &#916;GI-2/c). These results show that none of these genetically well-characterized R isolates carried more than one R-linked mutation and, in addition, support the hypothesis that the protein encoded by BMEI0999 plays a role in O-PS synthesis. In summary, the results showed that two previously described dissociation mechanisms, <italic toggle="yes">int</italic>-dependent (for GI-2 excision) and <italic toggle="yes">wbk</italic> IS-RecA dependent (for <italic toggle="yes">wbkA</italic>), are actually active in Rev 1.</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>Genetic and phenotypic characterization of spontaneous Rev 1 R mutants. (A)</bold> Southern blot analysis of <italic toggle="yes">B. melitensis</italic> Rev 1 spontaneous R variants with IS<italic toggle="yes">711</italic> (left panel), <italic toggle="yes">wbkA</italic> (center panel) and GI2 BMEI0999 (right panel) as probes. Note that, for the IS711 probe and <italic toggle="yes">B. melitensis</italic> Rev 1 and &#8710;<italic toggle="yes">wbkA</italic> but not &#8710;GI-2<italic toggle="yes">,</italic> the signal at 4.2&#160;kb corresponds to two bands (predicted MW 4.2 and 4.14&#160;kb). For simplicity, fragments with molecular masses lower than 3.8&#160;kb were omitted. <bold>(B)</bold> Western blot of purified R-LPS and S-LPS, Rev 1, <italic toggle="yes">wbkA</italic> and GI-2 R mutants and the corresponding complemented strains probed with anti-LPS antibodies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1297-9716-44-105-2.jpg"/></fig><p>Finally, to study whether &#8710;GI-2 and &#8710;<italic toggle="yes">wbkA</italic> excisions occurred during vaccine manufacturing, we examined three commercial Rev 1 lots with different levels of dissociation (see Material and methods). We identified the GI-2 and <italic toggle="yes">wbkA</italic> chromosomal scars in these commercial preparations (not shown) and, interestingly, the lot with the highest dissociation rate (almost 100%) presented both chromosomal scars. Considering these results and those of the above-described experiments, we concluded that GI-2 and <italic toggle="yes">wbkA</italic> deletions occur repeatedly in batches during manufacturing despite the precautions taken to minimize S-R dissociation.</p></sec><sec><title>The S-R dissociation of <italic toggle="yes">B. melitensis</italic> Rev 1 is reduced by mutation of GI-2 <italic toggle="yes">int</italic> and IS<italic toggle="yes">Bm1</italic> transposase flanking <italic toggle="yes">wbkA</italic></title><p>We have previously shown that disruption of GI-2 phage-related integrase <italic toggle="yes">int</italic> gene reduces the dissociation rate of <italic toggle="yes">B. abortus</italic> by stabilization of GI-2 [<xref ref-type="bibr" rid="B10">10</xref>]. To test whether this also occurs in <italic toggle="yes">B. melitensis</italic> Rev 1, we constructed mutant Rev 1&#916;<italic toggle="yes">int</italic> by in-frame deletion of GI-2 <italic toggle="yes">int</italic> (see Material and Methods). Similarly, we have previously shown that the excision of the 5.5&#160;kb fragment carrying <italic toggle="yes">wbkA</italic> is caused by homologous recombination mediated by RecA and the <italic toggle="yes">wbkA</italic>-flanking IS [<xref ref-type="bibr" rid="B14">14</xref>]. Thus, we also constructed mutant Rev 1&#916;IS<italic toggle="yes">Bm1</italic>, which lacks one of the <italic toggle="yes">wbkA</italic>-flanking IS<italic toggle="yes">Bm1</italic> copies. Characterization by PCR demonstrated only the scar and circular intermediate corresponding to GI-2 excision in Rev 1&#916;IS<italic toggle="yes">Bm1</italic> (Figure&#160;<xref ref-type="fig" rid="F3">3</xref>A), showing the stabilization of <italic toggle="yes">wbkA</italic>. Conversely, Rev 1&#916;<italic toggle="yes">int</italic> displayed the scar and circular intermediate corresponding to an excision of the <italic toggle="yes">wbkA</italic> (Figure&#160;<xref ref-type="fig" rid="F3">3</xref>A). To stabilize both genetic regions, we constructed the Rev 1&#916;IS<italic toggle="yes">Bm1</italic>&#916;<italic toggle="yes">int</italic> double mutant (Rev 2) on the Rev 1&#916;IS<italic toggle="yes">Bm1</italic> background. As expected, Rev 2 did not show evidence (scars or circular intermediates) of GI-2 or <italic toggle="yes">wbkA</italic> excision events by PCR (Figure&#160;<xref ref-type="fig" rid="F3">3</xref>A) even in experiments with high amounts of template DNA.</p><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>Stabilization of regions GI-2 and wbkA by deletion of appropriate section of GI-2 phage-related integrase (&#916;</bold><bold><italic toggle="yes">int</italic></bold><bold>), </bold><bold><italic toggle="yes">wbkA</italic></bold><bold>-flanking IS (&#916;</bold><bold><italic toggle="yes">ISBm1</italic></bold><bold>) and both (Rev 2). (A)</bold> PCR detection of the chromosomal scar and circular intermediate resulting from (GI-2 excision (left panel) and <italic toggle="yes">wbkA</italic> excision (right panel). <bold>(B)</bold> S-R dissociation rates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1297-9716-44-105-3.jpg"/></fig><p>Using the above mutants and the parental Rev 1 and <italic toggle="yes">B. melitensis</italic> H38 as references, we assessed the importance of the corresponding genetic mechanisms in the frequency of the S-R dissociation of Rev 1. To this end, we used conditions that favor the growth of R mutants and counted the proportions of R bacteria using the crystal violet exclusion method (see Material and methods, S-R dissociation assessment). While dissociation of strain H38 was beyond detection under the experimental conditions, Rev 1 showed dissociation rates of 4.27 &#177; 1.34% (Figure&#160;<xref ref-type="fig" rid="F3">3</xref>B). In contrast, the single mutants displayed lower (<italic toggle="yes">p</italic> &lt; 0.0001) dissociation rates than Rev 1. These dissociation rates were significantly (<italic toggle="yes">p</italic> &lt; 0.01) lower for Rev 1&#8710;<italic toggle="yes">int</italic> (0.38 &#177; 0.33) than for Rev 1&#916;IS<italic toggle="yes">Bm1</italic> (1.70 &#177; 0.38). Consistent with the prediction, the double mutant Rev 2 showed the lowest dissociation rates (0.17 &#177; 0.13%). Therefore, under these experimental conditions, GI-2 and <italic toggle="yes">wbkA</italic> stabilization resulted in an approximately 25-fold (i.e. about 95%) decrease in dissociation.</p></sec><sec><title>Stabilization of the S phenotype does not alter the properties of Rev 1 in vitro or in mice</title><p>Standard bacteriological characterization demonstrated that Rev 1&#916;IS<italic toggle="yes">Bm1,</italic> Rev 1&#916;<italic toggle="yes">int</italic> and Rev 2 conserved the phenotypic markers that are characteristic of Rev 1, namely: S phenotype (demonstrated by reactivity with anti-S antibodies and by the crystal violet and acriflavine tests), inhibition by 5&#160;IU/mL penicillin, resistance to 2.5&#160;&#956;g/mL of streptomycin, and comparatively small colony size (1&#8211;1.2&#160;mm diameter after 5&#160;days of incubation at 37&#160;&#176;C) [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Since the latter feature (i.e. slow growth) is a particularly important Rev 1 property ([<xref ref-type="bibr" rid="B33">33</xref>]; see also below), we compared the growth curves of Rev 1, Rev 2 and the wild-type <italic toggle="yes">B. melitensis</italic> H38 reference strain. As can be seen in Figure&#160;<xref ref-type="fig" rid="F4">4</xref>A, Rev 1 and Rev 2 produced almost identical growth curves and both were retarded with respect to <italic toggle="yes">B. melitensis</italic> H38.</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold>Genetic stabilization in Rev 2 does not alter the in vitro growth and vaccine properties of Rev 1 reference vaccine. (A)</bold> In vitro growth kinetics; <bold>(B)</bold> Residual virulence (log CFU/spleen); <bold>(C)</bold> Spleen weights; and <bold>(D)</bold> Efficacy against a virulent <italic toggle="yes">B. melitensis</italic> virulent challenge, in BALB/c mice. Statistical comparison of means was performed by one-way ANOVA and Fisher&#8217;s PLSD test: <sup>a</sup><italic toggle="yes">P</italic> &lt; 0.005 vs. unvaccinated control (PBS group).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1297-9716-44-105-4.jpg"/></fig><p>We completed the characterization of Rev 2 by studying whether the critical biological properties of Rev 1 (i.e. residual virulence and efficacy against virulent infection) were maintained in Rev 2. For this purpose, we used the established mouse model for brucellosis vaccine control [<xref ref-type="bibr" rid="B34">34</xref>], which is useful in discriminating Rev 1 vaccine lots of inappropriate residual virulence and immunogenicity [<xref ref-type="bibr" rid="B25">25</xref>]. Rev 2 showed a behavior almost identical to that of Rev 1 in this model. In virulence assays, both strains persisted similarly and less than the virulent <italic toggle="yes">B. melitensis</italic> H38 strain (Figure&#160;<xref ref-type="fig" rid="F4">4</xref>B). Likewise, Rev 1 and Rev 2 induced a similarly reduced splenomegaly (Figure&#160;<xref ref-type="fig" rid="F4">4</xref>C). Finally, Rev 2 was as protective as Rev 1 against a challenge infection with the full-virulent <italic toggle="yes">B. melitensis</italic> H38-Nx<sup>R</sup> strain (Figure&#160;<xref ref-type="fig" rid="F4">4</xref>D).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>A major practical aspect of vaccine production is quality control. Because of the well-known genetic instability of all brucellae in vitro [<xref ref-type="bibr" rid="B34">34</xref>], control is particularly critical in brucellosis vaccines. Therefore, a manufacturing seed-lot system [<xref ref-type="bibr" rid="B33">33</xref>] has been adopted to reduce genetic drifts including the appearance of R types. In addition, control of every single batch includes the assessment of colony S phase and morphology [<xref ref-type="bibr" rid="B24">24</xref>]. As confirmed here by comparison with <italic toggle="yes">B. melitensis</italic> H38, dissociation of <italic toggle="yes">B. melitensis</italic> Rev 1 into S and R forms is particularly troublesome and, although the reasons for this difference between the virulent bacteria and the vaccine are not known, it is possible to indicate probable causes. Our results indicate that the genetic mechanisms operating in Rev 1 dissociation are those described before for other S strains and, therefore, it seems unlikely that this Rev 1 trait follows particular genetic characteristics of this vaccine. A more probable possibility is suggested by the well-known fact that oxygen limitation and other conditions causing energy shortage facilitate the establishment of <italic toggle="yes">Brucella</italic> R variants [<xref ref-type="bibr" rid="B35">35</xref>]. Accordingly, we have proposed [<xref ref-type="bibr" rid="B14">14</xref>] that mutants not synthesizing the costly O-PS are more competitive when energy shortage and no selective pressure to maintain the O-PS concur and that, under these circumstances, the excision of GI-2 promoted by the phage-related integrase <italic toggle="yes">int</italic> gene and the deletion of <italic toggle="yes">wbkA</italic> by homologous recombination become prominent. In the case of Rev 1, it is known that this vaccine carries a defect in ribosomal protein S12 that relates to its streptomycin resistance [<xref ref-type="bibr" rid="B36">36</xref>]. In <italic toggle="yes">Salmonella</italic> Typhimurium, a similar S12 mutation causes streptomycin resistance, increased rates of ribosomal proofreading and, as a result, decreased rates of protein synthesis, reduced bacterial growth and attenuation [<xref ref-type="bibr" rid="B37">37</xref>]. Therefore, it seems likely that the S12 defect in Rev 1 is a major cause of reduced fitness and growth rates (and attenuation), both of which could be compensated for by the reduction in energy expenditure caused by at least (see below) the loss of O-PS, thereby favoring the growth of R mutants. In fact, Rev 1 is characterized by a small colony size and the S-R dissociation is often accompanied by the appearance of larger colonies not appropriate for vaccine use [<xref ref-type="bibr" rid="B25">25</xref>].</p><p>Although we investigated other known R-generating mutations, we only detected the GI-2 and <italic toggle="yes">wbkA</italic> deletions in Rev 1. Turse et al. [<xref ref-type="bibr" rid="B15">15</xref>] have shown that point mutations on <italic toggle="yes">manB</italic><sub>core</sub>, a gene required for the complete synthesis of O-PS [<xref ref-type="bibr" rid="B9">9</xref>], are a cause of spontaneous appearance of R variants, which have been isolated from infected macrophages and mice [<xref ref-type="bibr" rid="B15">15</xref>]. We failed to reveal any point mutations in this locus by sequencing <italic toggle="yes">manB</italic><sub>core</sub> in the 21 R strains that did not show either <italic toggle="yes">wbkA</italic> or GI-2 deletions. Since Turse et al. performed their experiments with <italic toggle="yes">B. abortus</italic> 2308 and <italic toggle="yes">B. melitensis</italic> 16&#160;M and recovered the R mutants using agar plates saturated with Bk2 phage (specific for the S-phase), it seems that the discrepancies could be explained by the use of different experimental conditions. Concerning the genetic mechanisms, we observed that inactivation of the GI-2 integrase had a more significant effect on O-PS stability. This may reflect a higher instability of this region related to the activity of the integrase and/or to the concomitant loss of Omp25b (a major outer membrane protein encoded in GI-2 [<xref ref-type="bibr" rid="B11">11</xref>]), since the ensuing reduction in biosynthetic expenditures would increase competitiveness in vitro. Another possibility is suggested by the fact that recombinases like the one coded for by GI-2 <italic toggle="yes">int</italic> are able to identify secondary target repeat sequences promoting the excision of unrelated fragments [<xref ref-type="bibr" rid="B38">38</xref>]. Therefore, the GI-2 integrase could theoretically take part in other events leading to the R phenotype. This work also shows that mutations other than those described thus far also cause the appearance of R types. This is shown by the fact that dissociation was not completely prevented in Rev 2 strain. Further investigations are necessary for a full understanding of the mutation paths that affect the O-PS in <italic toggle="yes">Brucella</italic>.</p><p>Because the underlying mechanisms were known, we could abrogate the GI-2 and <italic toggle="yes">wbkA</italic> deletions and generate a more stable Rev 2 strain. Indeed, as shown by the experimental results presented here, the absence of large sections of the DNA sequences involved in this deletion events make highly unlikely the possibility that Rev 2 could revert to an anomalously high S-R dissociation rate. Thus, the genetic strategy described here represents a complement to the empirical methods currently used in the production of smooth <italic toggle="yes">Brucella</italic> vaccines for the stabilization of smooth phenotype. Although the comparison between the virulent H38 strain and Rev 1 showed differences in both growth and S-R dissociation rates, our results demonstrate that the increased S-R dissociation is not linked to attenuation of Rev 1 in the mouse model, as it might be expected from the characteristic attenuation of <italic toggle="yes">Brucella</italic> R mutants. As discussed above, the reduced fitness probably caused by the S12 mutation that is manifested by the lower growth rates is a more likely cause of attenuation. Rev 2 conserved this characteristic and also the relevant biological properties of Rev 1 in the mouse model. Although this model represents the best laboratory control for the in vivo properties of Rev 1 [<xref ref-type="bibr" rid="B33">33</xref>], experiments in the natural hosts are clearly necessary to prove that Rev 2 retains all the properties that have made Rev 1 a succesful vaccine.</p></sec><sec><title>Competing interests</title><p>The authors declared that they have no competing interests.</p></sec><sec><title>Authors&#8217; contributions</title><p>MM designed and performed the molecular biology experiments. MJdM, AZB and BSR carried out the bacteriological studies and experiments in mice. ILG provided financial support. IM, MJG and MM designed the work and wrote the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1" position="float" orientation="portrait"><caption><title>Additional file 1</title><p><bold><italic toggle="yes">E. coli</italic></bold><bold> strains and plasmids used.</bold> List, characteristics and source/reference of <italic toggle="yes">E. coli</italic> strains and plasmids used.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1297-9716-44-105-S1.docx" position="float" orientation="portrait"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>This work was funded by MINECO (reference project AGL2011-30453-C04) of Spain, the FIMA foundation and the European Union&#8217;s FP7/2007-2013 (grant agreement n&#176; 221948, ICONZ - Integrated control of Neglected Zoonoses) and CSIC JAE-Doc program (FSE). We thank to Prof. G. Splitter (Animal Health and Biomedical Sciences, University of Wisconsin-Madison, USA) for providing plasmid pBGI-99-97c, Dr J.M. Blasco (Sanidad Animal, CITA of Arag&#243;n, Spain) for the vaccine Rev 1 seed lot and strains, and A. Delgado for skillfull technical assistance.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name name-style="western"><surname>Grace</surname><given-names>D</given-names></name><name name-style="western"><surname>Mutua</surname><given-names>F</given-names></name><name name-style="western"><surname>Ocungo</surname><given-names>P</given-names></name><name name-style="western"><surname>Kruska</surname><given-names>R</given-names></name><name name-style="western"><surname>Jones</surname><given-names>K</given-names></name><name name-style="western"><surname>Brierley</surname><given-names>L</given-names></name><name name-style="western"><surname>Lapar</surname><given-names>L</given-names></name><name name-style="western"><surname>Said</surname><given-names>M</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>M</given-names></name><name name-style="western"><surname>Duc Phuc</surname><given-names>P</given-names></name><name name-style="western"><surname>Elich Tao</surname><given-names>N</given-names></name><name name-style="western"><surname>Akuku</surname><given-names>I</given-names></name><name name-style="western"><surname>Ogutu</surname><given-names>F</given-names></name><article-title>Mapping of poverty and likely zoonoses hotspots</article-title><source>Zoonoses Project</source><year>2012</year><volume>4</volume><fpage>1</fpage><lpage>119</lpage></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><collab>Anonymous</collab><source>The control of Neglected Zoonoses Diseases: A route to poverty alleviation</source><year>2006</year><publisher-name>Geneva: WHO Press</publisher-name></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><article-title>A review of the use of <italic toggle="yes">B. melitensis</italic> Rev 1 vaccine in adult sheep and goats</article-title><source>Prev Vet Med</source><year>1997</year><volume>31</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/S0167-5877(96)01110-5</pub-id><pub-id pub-id-type="pmid">9234451</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Mainar-Jaime</surname><given-names>RC</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status</article-title><source>Vet Res</source><year>2004</year><volume>35</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1051/vetres:2003037</pub-id><pub-id pub-id-type="pmid">15099501</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name name-style="western"><surname>Barrio</surname><given-names>MB</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>De-Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barberan</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><article-title>Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against <italic toggle="yes">Brucella melitensis</italic> infection of sheep</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>1741</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.025</pub-id><pub-id pub-id-type="pmid">19186196</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name name-style="western"><surname>Godfroid</surname><given-names>J</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>HC</given-names></name><name name-style="western"><surname>Barbier</surname><given-names>T</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>C</given-names></name><name name-style="western"><surname>Wattiau</surname><given-names>P</given-names></name><name name-style="western"><surname>Fretin</surname><given-names>D</given-names></name><name name-style="western"><surname>Whatmore</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Saegerman</surname><given-names>C</given-names></name><name name-style="western"><surname>Muma</surname><given-names>JB</given-names></name><name name-style="western"><surname>Al-Dahouk</surname><given-names>S</given-names></name><name name-style="western"><surname>Neubauer</surname><given-names>H</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><article-title>Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century</article-title><source>Prev Vet Med</source><year>2011</year><volume>102</volume><fpage>118</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2011.04.007</pub-id><pub-id pub-id-type="pmid">21571380</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name name-style="western"><surname>Minas</surname><given-names>A</given-names></name><name name-style="western"><surname>Minas</surname><given-names>M</given-names></name><name name-style="western"><surname>Stournara</surname><given-names>A</given-names></name><name name-style="western"><surname>Tselepidis</surname><given-names>S</given-names></name><article-title>The &#8220;effects&#8221; of Rev-1 vaccination of sheep and goats on human brucellosis in Greece</article-title><source>Prev Vet Med</source><year>2004</year><volume>64</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2004.03.007</pub-id><pub-id pub-id-type="pmid">15219968</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="book"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name><name name-style="western"><surname>Jones</surname><given-names>LM</given-names></name><name name-style="western"><surname>Angus</surname><given-names>RD</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><source>Techniques for the brucellosis laboratory</source><year>1988</year><publisher-name>Paris, France: INRA</publisher-name></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>De-Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>RM</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>A</given-names></name><name name-style="western"><surname>Widmalm</surname><given-names>G</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><article-title>Brucellosis vaccines: assessment of <italic toggle="yes">Brucella melitensis</italic> lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e2760</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002760</pub-id><pub-id pub-id-type="pmid">18648644</pub-id><pub-id pub-id-type="pmcid">PMC2453230</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name name-style="western"><surname>Mancilla</surname><given-names>M</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Zarraga</surname><given-names>AM</given-names></name><article-title>Genomic Island 2 is an unstable genetic element contributing to <italic toggle="yes">Brucella</italic> lipopolysaccharide spontaneous smooth-to-rough dissociation</article-title><source>J Bacteriol</source><year>2010</year><volume>192</volume><fpage>6346</fpage><lpage>6351</lpage><pub-id pub-id-type="doi">10.1128/JB.00838-10</pub-id><pub-id pub-id-type="pmid">20952568</pub-id><pub-id pub-id-type="pmcid">PMC3008527</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N</given-names></name><name name-style="western"><surname>Caro-Hernandez</surname><given-names>P</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Fernandez-Lago</surname><given-names>L</given-names></name><article-title>DNA polymorphism in the omp25/omp31 family of <italic toggle="yes">Brucella</italic> spp.: identification of a 1.7-kb inversion in <italic toggle="yes">Brucella cetaceae</italic> and of a 15.1-kb genomic island, absent from <italic toggle="yes">Brucella ovis</italic>, related to the synthesis of smooth lipopolysaccharide</article-title><source>Microbes Infect</source><year>2004</year><volume>6</volume><fpage>821</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2004.04.009</pub-id><pub-id pub-id-type="pmid">15374004</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name name-style="western"><surname>Garc&#237;a-Yoldi</surname><given-names>D</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><article-title>Restriction site polymorphisms in the genes encoding new members of group 3 outer membrane protein family of <italic toggle="yes">Brucella</italic> spp</article-title><source>FEMS Microbiol Lett</source><year>2005</year><volume>245</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.femsle.2005.02.026</pub-id><pub-id pub-id-type="pmid">15796983</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><name name-style="western"><surname>Mancek-Keber</surname><given-names>M</given-names></name><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name name-style="western"><surname>Palacios-Chaves</surname><given-names>L</given-names></name><name name-style="western"><surname>Chac&#243;n-D&#237;az</surname><given-names>C</given-names></name><name name-style="western"><surname>Chaves-Olarte</surname><given-names>E</given-names></name><name name-style="western"><surname>Martirosyan</surname><given-names>A</given-names></name><name name-style="western"><surname>Von-Bargen</surname><given-names>K</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Jerala</surname><given-names>R</given-names></name><name name-style="western"><surname>Brandenburg</surname><given-names>K</given-names></name><name name-style="western"><surname>Llobet</surname><given-names>E</given-names></name><name name-style="western"><surname>Bengoechea</surname><given-names>JA</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><article-title>The lipopolysaccharide core of <italic toggle="yes">Brucella abortus</italic> acts as a shield against innate immunity recognition</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><fpage>e1002675</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002675</pub-id><pub-id pub-id-type="pmid">22589715</pub-id><pub-id pub-id-type="pmcid">PMC3349745</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name name-style="western"><surname>Mancilla</surname><given-names>M</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>CM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zarraga</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><article-title>Spontaneous excision of the O-polysaccharide <italic toggle="yes">wbkA</italic> glycosyltranferase gene is a cause of dissociation of smooth to rough <italic toggle="yes">Brucella</italic> colonies</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>1860</fpage><lpage>1867</lpage><pub-id pub-id-type="doi">10.1128/JB.06561-11</pub-id><pub-id pub-id-type="pmid">22328663</pub-id><pub-id pub-id-type="pmcid">PMC3318470</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name name-style="western"><surname>Turse</surname><given-names>JE</given-names></name><name name-style="western"><surname>Pei</surname><given-names>J</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><article-title>Lipopolysaccharide-deficient <italic toggle="yes">Brucella</italic> variants arise spontaneously during infection</article-title><source>Front Microbiol</source><year>2011</year><volume>2</volume><fpage>54</fpage><pub-id pub-id-type="pmid">21833310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2011.00054</pub-id><pub-id pub-id-type="pmcid">PMC3153030</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name name-style="western"><surname>Vemulapalli</surname><given-names>R</given-names></name><name name-style="western"><surname>McQuiston</surname><given-names>JR</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Halling</surname><given-names>SM</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><article-title>Identification of an IS711 element interrupting the <italic toggle="yes">wboA</italic> gene of <italic toggle="yes">Brucella abortus</italic> vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other <italic toggle="yes">Brucella</italic> species and strains</article-title><source>Clin Diagn Lab Immunol</source><year>1999</year><volume>6</volume><fpage>760</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">10473532</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/cdli.6.5.760-764.1999</pub-id><pub-id pub-id-type="pmcid">PMC95769</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><article-title>DNA polymorphism analysis of <italic toggle="yes">Brucella</italic> lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough <italic toggle="yes">Brucella</italic> species and novel species-specific markers</article-title><source>BMC Microbiol</source><year>2009</year><volume>9</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-9-92</pub-id><pub-id pub-id-type="pmid">19439075</pub-id><pub-id pub-id-type="pmcid">PMC2698832</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name name-style="western"><surname>DelVecchio</surname><given-names>VG</given-names></name><name name-style="western"><surname>Kapatral</surname><given-names>V</given-names></name><name name-style="western"><surname>Redkar</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Patra</surname><given-names>G</given-names></name><name name-style="western"><surname>Mujer</surname><given-names>C</given-names></name><name name-style="western"><surname>Los</surname><given-names>T</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>N</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>I</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>A</given-names></name><name name-style="western"><surname>Lykidis</surname><given-names>A</given-names></name><name name-style="western"><surname>Reznik</surname><given-names>G</given-names></name><name name-style="western"><surname>Jablonski</surname><given-names>L</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>N</given-names></name><name name-style="western"><surname>D&#8217;Souza</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernal</surname><given-names>A</given-names></name><name name-style="western"><surname>Mazur</surname><given-names>M</given-names></name><name name-style="western"><surname>Goltsman</surname><given-names>E</given-names></name><name name-style="western"><surname>Selkov</surname><given-names>E</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PH</given-names></name><name name-style="western"><surname>Hagius</surname><given-names>S</given-names></name><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>D</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Haselkorn</surname><given-names>R</given-names></name><name name-style="western"><surname>Kyrpides</surname><given-names>N</given-names></name><name name-style="western"><surname>Overbeek</surname><given-names>R</given-names></name><article-title>The genome sequence of the facultative intracellular pathogen <italic toggle="yes">Brucella melitensis</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1073/pnas.221575398</pub-id><pub-id pub-id-type="pmid">11756688</pub-id><pub-id pub-id-type="pmcid">PMC117579</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="other"><article-title>National Center for Biotechnology Information/Basic Local Aligment Search Tool (NCBI/BLAST)</article-title><comment>[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST">http://www.ncbi.nlm.nih.gov/BLAST</ext-link>]</comment></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="other"><article-title>European Molecular Biology Laboratory-European Bioinformatics Institute (EMBI-EBI)</article-title><comment>[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/clustalo">http://www.ebi.ac.uk/Tools/clustalo</ext-link>]</comment></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="other"><article-title>National Center for Biotechnology Information/Primer-BLAST (NCBI/Primer-BLAST)</article-title><comment>[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/">http://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link>]</comment></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="other"><name name-style="western"><surname>Wilson</surname><given-names>K</given-names></name><article-title>Preparation of genomic DNA from bacteria</article-title><source>Curr Protoc Mol Biol</source><year>1997</year><fpage>2.4.1</fpage><lpage>2.4.5</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/0471142727.mb0204s56</pub-id><pub-id pub-id-type="pmid">18265184</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ocampo-Sosa</surname><given-names>AA</given-names></name><name name-style="western"><surname>Aguero-Balbin</surname><given-names>J</given-names></name><name name-style="western"><surname>Garcia-Lobo</surname><given-names>JM</given-names></name><article-title>Development of a new PCR assay to identify <italic toggle="yes">Brucella abortus</italic> biovars 5, 6 and 9 and the new subgroup 3b of biovar 3</article-title><source>Vet Microbiol</source><year>2005</year><volume>110</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2005.06.007</pub-id><pub-id pub-id-type="pmid">16029934</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name name-style="western"><surname>Bosseray</surname><given-names>N</given-names></name><article-title><italic toggle="yes">Brucella melitensis</italic> Rev.1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice</article-title><source>Biologicals</source><year>1991</year><volume>19</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/S1045-1056(05)80025-9</pub-id><pub-id pub-id-type="pmid">1797046</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bosseray</surname><given-names>N</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><article-title>In vitro markers and biological activity in mice of seed lot strains and commercial <italic toggle="yes">Brucella melitensis</italic> Rev 1 and <italic toggle="yes">Brucella abortus</italic> B19 vaccines</article-title><source>Biologicals</source><year>2000</year><volume>28</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1006/biol.2000.0249</pub-id><pub-id pub-id-type="pmid">10885618</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>SP</given-names></name><name name-style="western"><surname>De-Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Fugier</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M</given-names></name><article-title>Synthesis of phosphatidylcholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite <italic toggle="yes">Brucella abortus</italic></article-title><source>Cell Microbiol</source><year>2006</year><volume>8</volume><fpage>1322</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2006.00712.x</pub-id><pub-id pub-id-type="pmid">16882035</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name name-style="western"><surname>Quandt</surname><given-names>J</given-names></name><name name-style="western"><surname>Hynes</surname><given-names>MF</given-names></name><article-title>Versatile suicide vectors which allow direct selection for gene replacement in gram-negative bacteria</article-title><source>Gene</source><year>1993</year><volume>127</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(93)90611-6</pub-id><pub-id pub-id-type="pmid">8486283</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name name-style="western"><surname>Simon</surname><given-names>R</given-names></name><name name-style="western"><surname>Priefer</surname><given-names>U</given-names></name><name name-style="western"><surname>Pehle</surname><given-names>A</given-names></name><article-title>A broad host range mobilization system for the <italic toggle="yes">in vitro</italic> genetic engineering: transposon mutagenesis in gram negative bacteria</article-title><source>Biotechnology</source><year>1983</year><volume>1</volume><fpage>784</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1038/nbt1183-784</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name name-style="western"><surname>Rajashekara</surname><given-names>G</given-names></name><name name-style="western"><surname>Covert</surname><given-names>J</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>E</given-names></name><name name-style="western"><surname>Eskra</surname><given-names>L</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>G</given-names></name><article-title>Genomic island 2 of <italic toggle="yes">Brucella melitensis</italic> is a major virulence determinant: Functional analyses of genomic islands</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><fpage>6243</fpage><lpage>6252</lpage><pub-id pub-id-type="doi">10.1128/JB.00520-08</pub-id><pub-id pub-id-type="pmid">18641138</pub-id><pub-id pub-id-type="pmcid">PMC2546784</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="other"><article-title>Oy Growth Curves Ab Ltd</article-title><comment>[<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.bioscreen.fi">http://www.bioscreen.fi</ext-link>]</comment></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name name-style="western"><surname>Arag&#243;n</surname><given-names>V</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><article-title>Characterization of <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella melitensis</italic> native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide</article-title><source>J Bacteriol</source><year>1996</year><volume>178</volume><fpage>1070</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">8576040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.178.4.1070-1079.1996</pub-id><pub-id pub-id-type="pmcid">PMC177767</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Manterola</surname><given-names>L</given-names></name><name name-style="western"><surname>De-Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Lopez-Go&#241;i</surname><given-names>I</given-names></name><article-title>Increases of efficacy as vaccine against <italic toggle="yes">Brucella abortus</italic> infection in mice by simultaneous inoculation with avirulent smooth <italic toggle="yes">bvrS</italic>/<italic toggle="yes">bvrR</italic> and rough <italic toggle="yes">wbkA</italic> mutants</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>2910</fpage><lpage>2916</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.12.038</pub-id><pub-id pub-id-type="pmid">16439039</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="book"><collab>OIE</collab><article-title>Bovine Brucellosis</article-title><source>Manual of Diagnostic Tests and Vaccines for Terrestrial Animals</source><year>2009</year><publisher-name>OIE</publisher-name><fpage>1</fpage><lpage>35</lpage><comment>Chapter 2.4.3</comment></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name name-style="western"><surname>Grill&#243;</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><article-title>What have we learned from brucellosis in the mouse model?</article-title><source>Vet Res</source><year>2012</year><volume>43</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-43-29</pub-id><pub-id pub-id-type="pmid">22500859</pub-id><pub-id pub-id-type="pmcid">PMC3410789</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gerhardt</surname><given-names>P</given-names></name><article-title>The nutrition of Brucellae</article-title><source>Bacteriol Rev</source><year>1958</year><volume>22</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/br.22.2.81-98.1958</pub-id><pub-id pub-id-type="pmcid">PMC180938</pub-id><pub-id pub-id-type="pmid">13546130</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Grepinet</surname><given-names>O</given-names></name><article-title>Identification of Brucella melitensis vaccine strain Rev.1 by PCR-RFLP based on a mutation in the rpsL gene</article-title><source>Vaccine</source><year>2002</year><volume>20</volume><fpage>2546</fpage><lpage>2550</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(02)00159-7</pub-id><pub-id pub-id-type="pmid">12057611</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name name-style="western"><surname>Maisnier-Patin</surname><given-names>S</given-names></name><name name-style="western"><surname>Berg</surname><given-names>OG</given-names></name><name name-style="western"><surname>Liljas</surname><given-names>L</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>DI</given-names></name><article-title>Compensatory adaptation to the deleterious effect of antibiotic resistance in <italic toggle="yes">Salmonella</italic> Typhimurium</article-title><source>Mol Microbiol</source><year>2002</year><volume>46</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03173.x</pub-id><pub-id pub-id-type="pmid">12406214</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name name-style="western"><surname>Manson</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gilmore</surname><given-names>MS</given-names></name><article-title>Pathogenicity island integrase cross-talk: a potential new tool for virulence modulation</article-title><source>Mol Microbiol</source><year>2006</year><volume>61</volume><fpage>555</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05262.x</pub-id><pub-id pub-id-type="pmid">16879637</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>